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Abstract 
Infectious Pancreatic Necrosis Virus (IPNV) is a member of the family Birnaviridae that has 
been linked to high mortalities in salmonids. Bacterial based systems as live vectors for the 
delivery of heterologous antigens offer a number of advantages as vaccination strategies. VP2 
is a structural viral protein of IPNV with immunogenicity effects. In this study IPNV was 
isolated from diseased fry of rainbow trout Oncorhynchus mykiss (Walbaum) using CHSE-
214. Then an expression vector was constructed for expression of viral protein VP2. The 
designed vector was constructed based upon pET-26b (+) with T7 promoter. A fragment 
containing the full length of the VP2 gene of Iranian Sp strain was amplified by PCR using 
genomic RNA of IPNV as template and cloned inpET-26b(+) plasmid. Recombinant structural 
viral protein VP2 was expressed as a soluble, N-terminal PelB fusion protein and secreted into 
the periplasmic space of Escherichia coli BL21(DE3) and Rosetta (DE3). The glucose, 
Isopropyl-β-D- thiogalactopyranoside (IPTG) was used as a chemical inducer for rVP2 
production in 37º C. The rVP2 was extracted from the periplasm by osmotic shock treatment. 
The presence of gene in bacterial system of E. coli was confirmed by gel electrophoresis 
technique. The constructed vector could efficiently express the rVP2 into the periplasmic space 
of E. coli. The successful cloning and expression of the structural viral protein gene into E. coli 
can be used for developing a useful and safe vaccine to control IPNV infection in Iranian fish 
industry. 
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Introduction 
The IPNV is a small, non-enveloped virus 
belonging to the family Birnaviridae, genus 
Aquabirnavirus (Dobos, 1995) and has 
been isolated from marine and fresh water 
fish, molluscs and crustaceans (Heppell et 
al., 1995). The genome of virus has two 
segments of double-stranded RNA that are 
surrounded with a single shelled, 
icosahedral capsid with 60 nm in diameter 
(Dobos et al., 1979; Macdonald and Gower, 
1981). Segment A is 3097 bp long and 
encodes four viral proteins, namely 
structural proteins VP2 and VP3, and 
nonstructural proteins VP4 and VP5 
(Dobos, 1995). Segment A contains a large 
open reading frame (ORF) that encodes a 
106-KDa polyprotein (2916 bases) which is 
co-translationally cleaved by VP4 to 
produce pre-VP2 (pVP2) and VP3 (Dobos 
and Rowe, 1977; Duncan et al., 1987; 
Galloux et al., 2004; Dadar et al., 2013).  
The protease activity dependable for this 
cleavage has been associated with the viral 
protein VP4 (Duncan et al., 1987; Magyar 
and Dobos, 1994). Pre- Viral protein 2 is 
further progressed by host cell proteases to 
form the mature outer capsid protein VP2 
(Magyar and Dobos, 1994) which builds 
about 60% of virion (Dobos, 1995) and 
contains the antigenic region depended on 
induction of neutralizing antibodies in the 
host (Heppell et al., 1995). 
     Viral Protein 2 and VP3 are the major 
structural and immunogenic polypeptides 
of the virus (Dobos and Roberts, 1983). 
There is a small ORF which overlaps with 
the amino terminal end of the large ORF 
and generates a 15-KDa (VP5) 
nonstructural polypeptide (Dadar et al., 
2013). Also the structural proteins of many 
viruses through self-assembly make 
specific aggregates in a kind of different 
expression systems (Noad and Roy, 2003; 
Garcea and Gissmann, 2004; Chackerian, 
2007; Roy and Noad, 2008). These virally 
derived particles generally resemble the 
native viruses in size and morphology that 
refer as virus like particles (VLPs) (Ludwig 
and Wagner, 2007) or these particles do not 
mimic the virus capsid in size and they have 
been ascribed to as subviral particles 
(SVPs) (Dhar et al., 2010). 
       Due to structural similarities, VLPs 
and SVPs show effective immune 
responses and serve as excellent candidates 
for the production of vaccines (Noad and 
Roy, 2003; Ramqvist et al., 2007; Dhar et 
al., 2010; Roldão et al., 2010). They have 
developed vaccines through attractive 
platform for the display of foreign epitopes 
or targeting molecules such as antigens, 
drugs and plasmids (Samuel, 2001; Garcea 
and Gissmann, 2004; Georgens et al., 2005; 
Patient et al., 2009; Brun et al., 2011).  
Virus like particles and SVPs have been 
produced from a wild range of viruses and 
have very advantages regarding safety and 
immunogenicity over previous approaches 
(Moon et al., 2004; Roy and Noad, 2008). 
Economic losses due to IPNV in salmonid 
farms were estimated to be very high 
(Akhlaghi and Hosseini, 2007; Ahmadi et 
al., 2013; Munang'andu et al., 2013) and 
these losses can be reduced as vaccines for 
salmonids become available based on killed 
virus or recombinantly produced viral 
protein (Mikalsen et al., 2004; Allnutt et 
al., 2007; Fridholm et al., 2007; 
Munang'andu et al., 2013). Among the five 
proteins of IPNV, VP2 has been 
demonstrated to possess neutralizing 
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epitopes (Wolf et al., 1960; Dobos and 
Roberts, 1983; Heppell et al., 1995; Moon 
et al., 2004). Recently it is demonstrated 
that VP2 gene of IPNV expressed in a yeast 
expression system forms SVPs that is 
antigenic and is capable of providing 
immunity against the native IPNV (Allnutt 
et al., 2007). Also findings of another 
researchers showed that the VP2 is 
important for immunogenicity of IPNV 
vaccine ( Fridholm et al., 2007; Dhar et al., 
2010; Munang'andu et al., 2013). Based on 
these reports, recombinant VP2 can be used 
as vaccine against IPNV. In this study a 
VP2 sequence was isolated from Iranian 
strain of IPNV (Dadar et al., 2013). Then 
the recombinant protein (rVP2) of Iranian 
IPNV expressed in periplasmic space of E. 
coli and the recombinant proteins 
characterized by SDS-PAGE. The aim of 
this study was to produce a recombinant 
structural protein of VP2 of Iranian IPNV 
in a prokaryotic system for possibly 
developing a native vaccine.  
 
Materials and methods  
Cell line and virus isolation 
Iranian isolate of Infection pancreatic 
necrosis virus (IRIPNV strain) was isolated 
from diseased fry of rainbow trout using 
CHSE-214. Moribund rainbow trout fry 
were collected during an outbreak of IPNV 
from 2010 to 2012 in different fish farms in 
North and West provinces of Mazandaran, 
Chaharmahal and Bakhtiari, and 
Kohgiluyeh and Boyer Ahmad of Iran. The 
farms were run on a flow-through system of 
fresh water with a temperature range of 12 
to 15ºC. From each farm, 30 moribund fish 
were selected and transferred to laboratory. 
Virus isolation from fry samples with 
disease clinical signs, such as darkening of 
the skin, abdominal swelling, cast-like 
pseudofaeces and loss of appetite was 
performed, according to the procedure 
described by the OIE with minor 
modification (Noad and Roy, 2003; Garcea 
and Gissmann, 2004; Chackerian, 2007; 
Roy and Noad, 2008). Each pool contained 
ten fry fishes (Dadar et al., 2013). Briefly, 
2 g of specimen were homogenized in 2ml 
of minimum essential medium (MEM, 
Sigma, St. Louis, Missouri, USA) and 
centrifuged at 3000x g for 10 min. The 
supernatant was used directly for cell 
culture inoculation. Chinook salmon 
embryo (CHSE-214) cells were cultured in 
MEM containing Earle’s salts, L-
glutamine, 25 mM Hepes, 10 % fetal 
bovine serum (FBS), 100 ng/ml of 
streptomycin sulphate, 100 IU penicillin G., 
and were incubated at 20 ºC, up to 70-90 % 
confluence in 24-well plates before 
inoculation. Then they were inoculated 
with 200 microliters of 1:10 and 1:100 
dilution of each prepared sample in parallel 
wells containing CHSE and incubated at 
15ºC. At 7 days post inoculation (dpi), the 
cultures were observed for cytopathic effect 
(CPE) and if they were negative, the 
cultures were used for the second passage. 
After subjecting to 1 freeze/thaw cycle, the 
cell culture lysates from 2 dilutions of each 
sample were pooled and centrifuged at 
2000 x g for 5 min. Then fresh CHSE cells 
were inoculated with the pooled first 
passage supernatant. Plates were incubated 
at 15ºC and monitored daily up to 21 dpi, 
for development of viral CPE. If no CPE 
was observed after a period of 21 dpi, the 
sample was recorded as negative for IPNV. 
When CPE was observed, IPNV was 
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confirmed by using an IPNV antigen (Ag) 
ELISA kit (BIO-X, Jemelle, Belgium), and 
the culture medium was removed and 
stored in -80 ºC.  
 
VP2 isolation 
Genomic RNA was extracted from IRIPNV 
strain (Roche, Mannheim, Germany). Since 
there was no data about Iranian IPNV 
isolates; the IPNV sequences was took from 
NCBI (http://www.ncbi.nlm.nih.gov/) and 
were aligned with Mega5 (Tamura,. et al., 
2007) and NCBI (Mutoloki & Evensen, 
2011). The primers were including FVP2 
(5' ATGAACACAAACAAGGCAAC 3') 
and RVP2 (5' GAC TAT GTC TCT CCA 
GCC CCA TGC 3') for VP2. Then the 
specific primers were designed according 
to VP2 conserved region. The genomic 
RNA was amplified using a one-step RT-
PCR procedure regarding manufacturer's 
protocol (Qiagen). Then the VP2 gene of 
Iranian Sp strain was amplified by one-step 
RT-PCR method (Qiagen, Germany). The 
PCR products were purified and sequenced. 
The sequence was registered in NCBI. 
 
Bacterial Strain  
E. coli strain BL21 F- ompT hsdSB (rB- mB-) 
gal dcm λ (DE3) and E. coli strain 
rosetta  F- ompT hsdSB (rB- mB
-) gal dcm λ 
(DE3) was used as a host for expression of 
rVP2 of IPNV. 
 
Construction of -pET-26b (+) plasmid  
The PET-26b (+) vector carrying the viral 
protein gene from IPNV was constructed in 
this work. Briefly, the designed plasmid 
consist of the strong inducible T7 promoter 
under the control of the lac– operator 
sequences, pel B leader, the ORF protein of 
interest, followed by the 6His– Tag and T7 
transcription terminator, an origin of 
replication, the β- lactamase gene under its 
own promoter to confer resistance to 
Kanamycin with the strong transcription 
terminator of phage λ. The viral protein 
gene was amplified in a 50 µl reaction 
mixture by using a Mastercycler with one 
step RT-PCR (Qiagen, Germany). The viral 
protein gene was amplified using DNA 
KAPA polymerase with primers 
incorporating specific recognition site for 
two restriction enzymes (RE) NcoI and 
BamHI (Fermentas, Lithuania). The REs 
were selected in order to achieve a 
directional cloning of the genes of interest 
into the expression vector pET-26b (+) at 
its multiple cloning sites (MCS). The 
amplified 1347 bps fragment was digested 
by NcoI and BamHI restriction enzymes 
and VP2 was inserted into the NcoI and 
BamHI cloning sites and followed by 
ligation into the corresponding site on the 
pET-26b (+) plasmid by T4 DNA Ligase 
(Fermentas, Lithuania) (Sambrook et al., 
2001). 
 
Transformation of recombinant plasmid 
into host cells 
The constructed plasmid was transformed 
using CaCl2 method into E. coli cells 
(Dagert and Ehrlich, 1979; Inoue et al., 
1990) and transforming clones were 
selected on LB (Luria- Bertani) medium 
(Merck, Germany) with 50 µg/ml 
Kanamycin. Plasmids were prepared by the 
alkaline lysis method (Bimboim and Doly, 
1979; Kado et al., 1981) and purified using 
plasmid kits (Fermentas, Lithuania) and 
followed by restriction digestion analyses. 
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The insertion was sequenced to confirm its 
integrity (Bioneer). 
 
Expression studies and protein gel 
electrophoresis 
A well grown colony of recombinant E. coli 
cells (carrying the VP2 gene of IPNV) 
inoculated in 5ml of LB broth containing 50 
µg/ml of  Kanamycin and followed by 
incubation at 37ºC overnight. It was grown 
in shaking incubator at 37ºC and after 
reaching OD600nm=0.7-1.0. The cells 
induced with 0.1 M IPTG for 3 hours 
(Fermentas, Lithuania). A part of the 
culture was used as negative control 
without adding IPTG (pre- induction). 
After 3 hours of additional growth at 37ºC; 
cells were harvested by centrifugation at 
5000 g for 10 min at 4ºC. Electrophoresis 
was performed in the presence of SDS 
according to the Laemmli method 
(Laemmli, 1970). The discontinuous gel 
consist of a 4% stacking and a 10% 
separating gel run on a vertical 
electrophoresis unit. The pellet of bacteria 
was resuspended in 200 µl of 2X sample 
buffer (5 ml of dH2O, 1 ml of 1 M Tris-Hcl,  
pH=6.8, 1 ml glycerol, 2 ml of 10% w/v 
SDS, 5 mg of bromophenol blue, 1 ml of β-
mercaptoethanol) prior to boiling at 100ºC 
for 5 min. After boiling, the samples were 
centrifuged at 11000 g for 2 min and 
supernatant was used as sample for sodium 
dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE). Gels were 
stained with Coomassie Brilliant Blue 
R250. The total protein pattern of 
recombinant bacteria was visualized on 
Coomassie brilliant blue stained gel. 
 
 
Results 
Virus isolation 
The Iranian IPNV isolate were separated 
from samples after the second passage on 
CHSE-214 cells. Moribund rainbow trout 
fries were collected during outbreaks of 
IPNV from 2010 to 2012 in different fish 
farms in North and West provinces of 
Mazandaran, Chaharmahal and Bakhtiari, 
and Kohgiluyeh and Boyer Ahmad of Iran. 
The farms were run on a flow-through 
system of fresh water with a temperature 
range of 12 to 15ºC. From each farm, 30 
moribund fish were selected and transferred 
to laboratory. The virus CPE were  spindle-
shaped cells and  pyknosis of nuclei that 
typically appear in 5-10 days after 
inoculation (Fig. 1). Isolation of the virus in 
cell culture was confirmed by IPNV antigen 
ELISA Kit. 
 
VP2 Gene Isolation 
The specific primer pair amplified the full 
length of VP2 gene from extracted viral 
RNA successfully. The reactions amplified 
the fragment of 1347 bp as expected. The 
amplified fragment were sequenced and 
deposited in the NCBI database with 
accession number KC489465. 
 
Over expression of VP2 
The plasmid pET-26b (+) was used for 
targeting VP2 to the E. coli. The viral VP2 
gene was amplified using DNA KAPA 
polymerase with specific primers 
incorporating specific recognition site for 
two restriction enzymes (RE) NcoI and 
BamHI (Fig. 2). PCR amplification showed 
a band of 1347 bp which was in agreement 
with observations by other researchers. The 
schematic map of the construct carrying the 
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VP2 gene has shown in Fig. 3. Ten 
recombinant colonies were selected and 
sub-cultured in medium supplemented with 
50 mg/l Kanamycin. The extracted 
plasmids, pET-26b (+) rVP2, were 
analyzed by RE digestion and showed 
successful cloning of VP2 gene into E. coli. 
Cloning was further verified by DNA 
sequencing. For recombinant protein 
production, the constructed vector 
encoding rVP2 was transformed into E. coli 
BL21 (DE3) and Rosseta (DE3). The 
expression of the recombinant protein was 
induced using IPTG at final concentrations 
of 0.2 mM at 37ºC. Following the 
induction, the total protein of non-induction 
and induction cells were on a SDS-PAGE 
after 3 hours (Fig. 4). The presence of 
corresponding protein bands with a weight 
of 54 kDa, confirmed the expression of 
rVP2. Expression of rVP2 could be 
detected in both strains of E. coli (BL21 and 
Rosetta).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Phase contrast micrographs of CHSE-214 cells infected with IPNV. 
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Figure 2: PCR amplification of the structural 
viral protein gene of Iranian Infectious 
pancreatic necrosis virus isolated from 
cell culture. Lane 1: Gene Ruler 1 kb 
DNA Ladder #SM0311 Fermentas.TM, 
Lanes 2, 3, 4 and 5: PCR products of the 
VP2 gene of Iranian 
Infectiouspancreatic necrosis virus 
which is isolated from the cell culture. 
 
 
Figure 3: Schematic map of the recombinant 
pET-26b (+) VP2 plasmid. The unique 
restriction sites inserted into the 
designed plasmid are NcoI and BamHI. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: SDS-PAGE analysis of rVP2 periplasmic expression 
in E. coli BL21 and Rosetta. M: Protein marker, Page Ruler 
prestained protein ladder (#SM0671 Fermentas). Lane1: 
Control before IPTG addition. Lane2: Control 3h after IPTG 
addition; total soluble proteins extracted from 
untransformed E. coli BL21and Rosetta strains having the 
pET-26b (+) plasmid. Lane 3: Total soluble proteins extracted 
from transformed E. coli strains containing the recombinant 
pET-26b (+) rVP2 plasmid and 3 h after induction by 0.2 mM 
IPTG, Lane 4, Total soluble proteins extracted from 
transformed E. coli strains containing the recombinant pET-
26b (+) rVP2 plasmid, without induction. 
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Discussion 
Viral diseases are usually regarded as the 
major factors of mortality and economic 
losses in aquaculture. Despite the 
importance of these diseases, there  are few 
antiviral drugs for treatment of such cases 
(Kibenge et al., 2012). Vaccination is a 
very effective way of protecting animals 
against infectious disease which can 
significantly reduce mortality (Tarrab et al., 
1995; Munang'andu et al., 2013). 
     Since antiviral drugs have not yet found 
their way into aquaculture, vaccination 
against viral diseases can be considered as 
an approach for reducing mortality. An 
IPNV vaccine from company Norvax® 
Protect (NP) has been developed on the 
basis of rVP2 (Frost and Ness, 1997). 
Infection pancreatic necrosis vaccines have 
been available for a long time but their 
efficacy has been variable. The presence of 
a structural resembling neutralization 
epitope on recombinant VP2 (rVP2) for 
controlling Sp serotype strain has been  
demonstrated (Frost and Ness, 1997).  
      Most of neutralizing monoclonal 
antibodies which react with epitopes of 
IPNV, are located in VP2 region (Caswell-
Reno et al., 1989; Tarrab et al., 1995; Frost 
and Ness, 1997; Labus et al., 2001). Two 
variables and one conserved neutralization 
epitopes are located  in the central third part 
of VP2 (Frost and Ness, 1997).  Different 
genetic constructs have been made to 
express the capsid proteins for the 
expression and self-assembly of these 
proteins into VLPs and SVPs in different 
hosts including bacteria (Brun et al., 2011), 
insects (Shivappa et al., 2004), yeast 
(Allnutt et al., 2007), plant (Santi et al., 
2008) and mammalian cells (Labus et al., 
2001). The reason for the varying immune 
response to these vaccines has not been 
well defined and studies on the importance 
of using vaccine trains homologous to the 
virulent field strain has been conclusive 
(Munang'andu et al., 2013).  
      In this study the VP2 gene from 
IRIPNV isolate were amplified and 
sequenced using specific primers by RT-
PCR. The gene of interest was cloned into 
pET-26b (+). Cloning verification was 
carried out by restriction enzyme digestion 
and DNA sequencing. The band of 54 kDa 
were detected in SDS-PAGE. Also the 
results showed that the recombinant VP2 
can be expressed into both of strains of E. 
coli BL21 (DE3) and Rosetta (DE3). To our 
knowledge; this is the first report of 
isolation and expression of VP2 in Iranian 
IPNV isolates. The VP2 gene from IPNV 
was previously cloned and shown to form 
SVPs in yeast (Allnutt et al., 2007; Dhar et 
al., 2010), bacteria (Tarrab et al., 1995; 
Moon et al., 2004) expression systems. The 
SVPs and VLPs containing VP2 induce an 
immune response in salmon and rainbow 
trout (Galloux et al., 2004). Moreover, 
recent studies showed  that the residues of 
the VP2 capsid play a key role for 
immunogenicity of IPNV vaccines 
(Munang'andu et al., 2013). Furthermore, 
several homologous and heterologous 
genes  are successfully expressed in E. coli 
(Inoue et al., 1990) and  they were 
extensively engineered for the production 
of heterologous therapeutic proteins. The 
periplasmic space of E. coli is known for 
functional production of a variety of 
recombinant proteins, specially those 
which show toxic effects on host cells, or 
need oxidizing environment of periplasm 
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for appropriate formation of structural 
disulfide bonds (Hannig and Makrides, 
1998; Harvey et al., 2004; Memari et al., 
2010; Gholipour et al., 2010; Morowvat et 
al., 2014). SDS-PAGE analysis of rVP2 
showed the expression of the viral protein 
in a same molecular weight that was in 
agreement with the reported and expected 
size. The results of our study can be used in 
development of recombinant vaccines for 
IPNV. While vaccination in aquaculture is 
yet in initial steps (Evensen, 2009), one of 
the most promising and urgent applications 
of rVP2 is to investigate their use in 
introducing a recombinant vaccine (Dhar et 
al., 2014). The recombinant VP2 can be 
used as part of a commercial injectable 
polyvalent or monovalent vaccines as well 
as development of new diagnostic kits.  
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